On October 12th, in Toronto, Ontario, ASBM participated in an educational webinar for the Ontario Hospital Association, which represents 150 hospitals in the Canadian province. ASBM Executive Director Michael Reilly participated on a panel with Canadian physicians, patients, and industry representatives. Around 100 attendees were present.


Mr. Reilly discussed the state of biosimilar uptake globally. He described U.S. and European polices on biosimilar approval, naming and substitution, and how they compare and contrast to those of Canada.